| Date | Time | Source | Announcement |
|---|---|---|---|
| 26 May 2004 | 07:00 AM | Transaction in Own Shares | |
| 25 May 2004 | 07:00 AM | Transaction in Own Shares | |
| 24 May 2004 | 07:00 AM | Transaction in Own Shares | |
| 21 May 2004 | 07:00 AM | Transaction in Own Shares | |
| 20 May 2004 | 07:00 AM | Global Bond Offer | |
| 20 May 2004 | 07:00 AM | Transaction in Own Shares | |
| 19 May 2004 | 07:00 AM | Transaction in Own Shares | |
| 14 May 2004 | 07:00 AM | Capital Group | |
| 12 May 2004 | 07:00 AM | Advanta | |
| 07 May 2004 | 09:00 AM | AGM Resolutions | |
| 06 May 2004 | 07:00 AM | Seroquel | |
| 05 May 2004 | 10:42 AM | Regulatory Approval | |
| 30 Apr 2004 | 06:30 PM | Doc re. Pricing Supplement | |
| 30 Apr 2004 | 06:21 PM | Doc re. Pricing Supplement | |
| 30 Apr 2004 | 02:36 PM | Doc re. Pricing Supplement | |
| 30 Apr 2004 | 02:31 PM | Doc re. Pricing Supplement | |
| 29 Apr 2004 | 04:41 PM | Result of Meeting | |
| 29 Apr 2004 | 10:00 AM | 1st Quarter Results - Part 2 | |
| 29 Apr 2004 | 10:00 AM | 1st Quarter Results - part 1 | |
| 28 Apr 2004 | 09:00 AM | Notice of Results | |
| 29 Mar 2004 | 04:00 PM | Director Shareholding | |
| 22 Mar 2004 | 03:00 PM | Tender Offer | |
| 22 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 19 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 18 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 17 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 15 Mar 2004 | 04:00 PM | Notice of AGM | |
| 15 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 12 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 11 Mar 2004 | 10:00 AM | Directorate Change | |
| 09 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 08 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 04 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 02 Mar 2004 | 12:00 PM | Director Shareholding | |
| 01 Mar 2004 | 07:00 AM | Transaction in Own Shares | |
| 26 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 25 Feb 2004 | 10:00 AM | Annual Report and Accounts | |
| 24 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 23 Feb 2004 | 07:00 AM | REPURCHASE OF SHARES | |
| 20 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 19 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 16 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 13 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 12 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 11 Feb 2004 | 09:52 AM | Holding(s) in Company | |
| 11 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 09 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 04 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 03 Feb 2004 | 07:00 AM | Transaction in Own Shares | |
| 02 Feb 2004 | 07:00 AM | Transaction in Own Shares |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.